NOTICE OF ALLOWANCE - ISSUED
issued
on 09 Jul 2024
Last Applicant/ Owned by
700 Main Street North
Cambridge
MA
02139
Serial Number
90747075 filed on 01st Jun 2021
Registration Number
N/A
Correspondent Address
CHRISTINA M. LICURSI
Filing Basis
1. intent to use current
2. filed as use application
3. use application currently
Disclaimer
NO DATA
EIKONIZO THERAPEUTICS
(Based on Use in Commerce) Research and development in the field of drug discovery, imaging agents, biotechnology and pharmaceuticals (Based on Use in Commerce) Providing a website featuring information in the field of treatment for medical conditions (Based on Intent to Use) Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of neurodegenerative and neurological diseases Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
(Based on Use in Commerce) Providing a website featuring information in the field of treatment for medical conditions
First Use Date in General
30th Apr 2017
First Use Date in Commerce
30th Apr 2017
Class [042]
Computer & Software Services & Scientific Services
(Based on Use in Commerce) Research and development in the field of drug discovery, imaging agents, biotechnology and pharmaceuticals
First Use Date in General
30th Apr 2017
First Use Date in Commerce
30th Apr 2017
Class [005]
Pharmaceutical Products
(Based on Intent to Use) Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances or the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; diagnostic agents, preparations, substances and diagnostic materials in the form of preparations for medical purposes; imaging agents for positron emission tomography (PET) imaging for delivery of materials to target sites within the body for diagnostic purposes; imaging agents for positron emission tomography (PET) imaging for use in detecting disease, namely, radio tracers for positron emission tomography (PET) imaging
First Use Date in General
N/A
First Use Date in Commerce
N/A
Specimens
Mark Details
Serial Number
No 90747075
Mark Type
No Service Mark
Attorney Docket Number
No E05812000000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Jul 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 14th May 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 14th May 2024 | PUBLISHED FOR OPPOSITION |
| 24th Apr 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 11th Apr 2024 | EXPARTE APPEAL TERMINATED |
| 10th Apr 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 27th Apr 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 27th Apr 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 26th Apr 2023 | EX PARTE APPEAL-INSTITUTED |
| 26th Apr 2023 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |